• email
  • rss
  • twitter
  • facebook
  • linkedin
  • News
  • Investors
  • Contact

Ceapro Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Quality Management System
    • Sustainability
  • Technologies
    • Overview
    • Ethanol Fractionation Processes
    • Pressurized Gas Expanded (PGX) Technology
    • Chromatography Purification
    • Intellectual Property
    • Scientific Publications
  • Pipeline
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
    • Product Brochures
  • Cosmeceuticals
    • Overview
  • Nutraceuticals
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
  • Business Development
    • Overview
    • Partners
  • News
  • Investors
  • Contact
  • Home
  • Investors
  • Financial Information
  • Financial Reports
Navigation
  • Overview
  • News / Events
  • Company Information
  • Financial Information
    • Financial Reports
  • Stock Data
  • Corporate Governance
  • SEDAR
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Financial Reports

Q3 2022 Financial Report

Q3 2022 Financial Report

Q2 2022 Financial Report

Q2 2022 Financial Report

Q1 2022 Financial Report

Q1 2022 Financial Report

2021 Annual Report

2021 Annual Report

2021 Year End Consolidated Financial Statements

2021 Year End Consolidated Financial Statements

2021 Third Quarter Report

2021 Third Quarter Report

2021 Second Quarter Report

2021 Second Quarter Report

2021 First Quarter Report

2021 First Quarter Report

2020 Annual Report

2020 Annual Report

2020 Year End Consolidated Financial Statements

2020 Year End Consolidated Financial Statements

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next »

Sign up for email ALERTS Be the first to receive news and updates on Ceapro. Sign Up

  • © 2023 Ceapro Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap